These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Beclin 1 is required for starvation-enhanced, but not rapamycin-enhanced, LC3-associated phagocytosis of Burkholderia pseudomallei in RAW 264.7 cells. Li X; Prescott M; Adler B; Boyce JD; Devenish RJ Infect Immun; 2013 Jan; 81(1):271-7. PubMed ID: 23115045 [TBL] [Abstract][Full Text] [Related]
3. The Burkholderia pseudomallei type III secretion system and BopA are required for evasion of LC3-associated phagocytosis. Gong L; Cullinane M; Treerat P; Ramm G; Prescott M; Adler B; Boyce JD; Devenish RJ PLoS One; 2011 Mar; 6(3):e17852. PubMed ID: 21412437 [TBL] [Abstract][Full Text] [Related]
4. Genome wide transcriptome profiling of a murine acute melioidosis model reveals new insights into how Burkholderia pseudomallei overcomes host innate immunity. Chin CY; Monack DM; Nathan S BMC Genomics; 2010 Nov; 11():672. PubMed ID: 21110886 [TBL] [Abstract][Full Text] [Related]
5. Rab32 GTPase, as a direct target of miR-30b/c, controls the intracellular survival of Burkholderia pseudomallei by regulating phagosome maturation. Hu ZQ; Rao CL; Tang ML; Zhang Y; Lu XX; Chen JG; Mao C; Deng L; Li Q; Mao XH PLoS Pathog; 2019 Jun; 15(6):e1007879. PubMed ID: 31199852 [TBL] [Abstract][Full Text] [Related]
6. Evolution of Yu D; Yin Z; Jin Y; Zhou J; Ren H; Hu M; Li B; Zhou W; Liang L; Yue J Biomed Res Int; 2016; 2016():6745028. PubMed ID: 28018913 [TBL] [Abstract][Full Text] [Related]
7. Burkholderia pseudomallei type III secretion system cluster 3 ATPase BsaS, a chemotherapeutic target for small-molecule ATPase inhibitors. Gong L; Lai SC; Treerat P; Prescott M; Adler B; Boyce JD; Devenish RJ Infect Immun; 2015 Apr; 83(4):1276-85. PubMed ID: 25605762 [TBL] [Abstract][Full Text] [Related]
8. Interactions of Listeria monocytogenes with the autophagy system of host cells. Lam GY; Czuczman MA; Higgins DE; Brumell JH Adv Immunol; 2012; 113():7-18. PubMed ID: 22244576 [TBL] [Abstract][Full Text] [Related]
9. Stimulation of autophagy suppresses the intracellular survival of Burkholderia pseudomallei in mammalian cell lines. Cullinane M; Gong L; Li X; Lazar-Adler N; Tra T; Wolvetang E; Prescott M; Boyce JD; Devenish RJ; Adler B Autophagy; 2008 Aug; 4(6):744-53. PubMed ID: 18483470 [TBL] [Abstract][Full Text] [Related]
10. Roles of autophagy in HIV infection. Dinkins C; Pilli M; Kehrl JH Immunol Cell Biol; 2015 Jan; 93(1):11-7. PubMed ID: 25385065 [TBL] [Abstract][Full Text] [Related]
11. Cell death and autophagy in tuberculosis. Moraco AH; Kornfeld H Semin Immunol; 2014 Dec; 26(6):497-511. PubMed ID: 25453227 [TBL] [Abstract][Full Text] [Related]
12. Burkholderia pseudomallei Capsule Exacerbates Respiratory Melioidosis but Does Not Afford Protection against Antimicrobial Signaling or Bacterial Killing in Human Olfactory Ensheathing Cells. Dando SJ; Ipe DS; Batzloff M; Sullivan MJ; Crossman DK; Crowley M; Strong E; Kyan S; Leclercq SY; Ekberg JAK; St John J; Beacham IR; Ulett GC Infect Immun; 2016 Jul; 84(7):1941-1956. PubMed ID: 27091931 [TBL] [Abstract][Full Text] [Related]
13. Manipulation of autophagy by bacteria for their own benefit. Ogawa M; Mimuro H; Yoshikawa Y; Ashida H; Sasakawa C Microbiol Immunol; 2011 Jul; 55(7):459-71. PubMed ID: 21707736 [TBL] [Abstract][Full Text] [Related]
14. Macroautophagy is essential for killing of intracellular Burkholderia pseudomallei in human neutrophils. Rinchai D; Riyapa D; Buddhisa S; Utispan K; Titball RW; Stevens MP; Stevens JM; Ogawa M; Tanida I; Koike M; Uchiyama Y; Ato M; Lertmemongkolchai G Autophagy; 2015; 11(5):748-55. PubMed ID: 25996656 [TBL] [Abstract][Full Text] [Related]
15. Burkholderia cenocepacia J2315 escapes to the cytosol and actively subverts autophagy in human macrophages. Al-Khodor S; Marshall-Batty K; Nair V; Ding L; Greenberg DE; Fraser ID Cell Microbiol; 2014 Mar; 16(3):378-95. PubMed ID: 24119232 [TBL] [Abstract][Full Text] [Related]
16. Involvement of signal regulatory protein α, a negative regulator of Toll-like receptor signaling, in impairing the MyD88-independent pathway and intracellular killing of Burkholderia pseudomallei-infected mouse macrophages. Baral P; Utaisincharoen P Infect Immun; 2012 Dec; 80(12):4223-31. PubMed ID: 22988019 [TBL] [Abstract][Full Text] [Related]
17. Burkholderia pseudomallei triggers canonical inflammasome activation in a human primary macrophage-based infection model. Lichtenegger S; Stiehler J; Saiger S; Zauner A; Kleinhappl B; Bernecker C; Schlenke P; Wagner GE; Krause K; Gastager M; Steinmetz I PLoS Negl Trop Dis; 2020 Nov; 14(11):e0008840. PubMed ID: 33137811 [TBL] [Abstract][Full Text] [Related]
18. Inflammasomes, Autophagy, and Cell Death: The Trinity of Innate Host Defense against Intracellular Bacteria. Krakauer T Mediators Inflamm; 2019; 2019():2471215. PubMed ID: 30728749 [TBL] [Abstract][Full Text] [Related]
19. Exploitation of host cells by Burkholderia pseudomallei. Stevens MP; Galyov EE Int J Med Microbiol; 2004 Apr; 293(7-8):549-55. PubMed ID: 15149030 [TBL] [Abstract][Full Text] [Related]
20. An Inv/Mxi-Spa-like type III protein secretion system in Burkholderia pseudomallei modulates intracellular behaviour of the pathogen. Stevens MP; Wood MW; Taylor LA; Monaghan P; Hawes P; Jones PW; Wallis TS; Galyov EE Mol Microbiol; 2002 Nov; 46(3):649-59. PubMed ID: 12410823 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]